Howard Sandler, MD, MS, FASTRO

Chair

Cedars-Sinai Medical Center, Los Angeles

EDUCATION

• MS, Physics, University of Connecticut, 1991
• MD, University of Connecticut, 1985
• BS, Physics (Summa Cum Laude), University of Connecticut, 1978

POSTGRADUATE EDUCATION

• Resident, Radiation Oncology, University of Pennsylvania, Philadelphia, 1986 - 1989
• Internship, Internal Medicine, St. Francis Hospital and Medical Center, Hartford, Connecticut, 1985 - 1986

ACADEMIC APPOINTMENTS

• Interim Director, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, 2017 - present
• Professor, Radiation Oncology, Cedars-Sinai Medical Center, Los Angeles, 2009 - present
• Professor, Radiation Oncology, University of Michigan, 2001 - 2008
• Associate Professor, Radiation Oncology, University of Michigan, 1995 - 2001
• Assistant Professor, Radiation Oncology, University of Michigan, 1989 - 1995

HOSPITAL APPOINTMENTS

• Cedars-Sinai Medical Center, Los Angeles, 2008 - present
• University of Michigan, 1989 - 2008

SERVICE TO ASTRO

• Co-chair, Hypofractionated Prostate Cancer Guidelines, 2016 - 2018
• Chair, ASTRO Prostate/GU Resource Panel, 2009 - present
• Member, Government Relations Committee, 2007 - present
• Vice-chair, 2014 - 2017
• Chair, 2017 - present
• FDA Subcommittee, 2007 - 2014, Chair 2009 - 2014
• ASCO-ASTRO-SUO Genitourinary Cancer Symposium, Program Committee/Steering Committee, 2007 - 2013
• Scientific Program Chair, 2010 meeting
• ASTRO Evidence-based Clinical Practice Guideline Panel: Role of Post-Operative Radiotherapy for Radical Prostatectomy, Research Council, 2007 - 2010
• ASTRO Member, Prostate Cancer Work Group, AUA-Physician Consortium for Performance Improvement, 2006
• ASTRO Advocacy Day Attendee, 2006 - present
• ASTRO Annual Meeting Abstract Reviewer, 2003 - present (most years)
• ASTRO Health Services Research Committee, 1999 - 2004

SERVICE TO OTHER ONCOLOGY OR RADIOLOGY ORGANIZATIONS

• AUA Localized Prostate Cancer Guidelines Panel, 2014 - 2016
• ASCO CancerProgress.Net, 2011 - 2014
• ASCO/ESPN Prostate Cancer Advisory Panel, 2010 - 2012
• ASCO Cost of Care Cancer Task Force, Patient Resources Subcommittee, 2008
• AACR/ASCO Workshop on Methods in Clinical Cancer Research, 2008 - 2009
• ASCO Cancer Communications Committee, 2006 - 2009
• ASCO Localized Prostate Cancer Expert Panel, 1998 - 2016
• RTOG/NRG Oncology, Chair, GU Cancer Committee, 1997 - 2018
• ABR Volunteer, 1997-present, Chair GU Cancer Oral Exam, 2012 - present
• SWOG Brain Committee, 1991-1997, Vice chair, 1994 - 1997

BIOGRAPHICAL SKETCH

My background has been in academic radiation oncology, first at the University of Michigan and recently at Cedars-Sinai Medical Center in Los Angeles. I am a firm believer in expanding our clinical radiation oncology knowledge base through carefully conducted clinical research and I have been active in RTOG/NRG Oncology in the design and leadership of prostate cancer clinical trials.

In parallel with my clinical trial activities, I have been active in service to ASTRO and other oncology organizations in part because, importantly, oncology organizations are often the official spokespersons for us as cancer specialists and organizations like ASTRO benefit from the voluntary efforts of its members. As a result of various service roles, including a brief stint at FDA, I have found a home in the ASTRO Government Relations Committee for a number of years, which has further emphasized for me the importance of ASTRO’s engagement with all of the governmental entities that can have a direct impact on the practice of medicine in general and radiotherapy specifically.